JAGSONPAL PHARMACEUTICALS
Back to Cashflow Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹35 Cr | ₹47 Cr | ₹6.91 Cr | ₹28 Cr | ₹12 Cr |
What is the latest Cash Flow from Operating Activities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹35 Cr |
Mar2023 | ₹47 Cr |
Mar2022 | ₹6.91 Cr |
Mar2021 | ₹28 Cr |
Mar2020 | ₹12 Cr |
How is Cash Flow from Operating Activities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹35 Cr | -24.63 | |
Mar2023 | ₹47 Cr | 574.79 | |
Mar2022 | ₹6.91 Cr | -75.50 | |
Mar2021 | ₹28 Cr | 137.46 | |
Mar2020 | ₹12 Cr | - |
Compare Cash Flow from Operating Activities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,736.4 Cr | 9.7% | -7.4% | 66.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,661.0 Cr | -1.8% | 2.7% | 49.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,496.0 Cr | -0.2% | -3.4% | 57% | Stock Analytics | |
CIPLA | ₹121,970.0 Cr | -0.7% | 0.6% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,877.0 Cr | -1.8% | 11.3% | 18% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,163.2 Cr | 1.9% | 0.5% | 41.9% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 9.7% |
-7.4% |
66.4% |
SENSEX | 0.7% |
-2% |
9.7% |
You may also like the below Video Courses